Identifying Predictors Of Response To Mepolizumab In CRSwNP

This study is about a condition called Chronic Rhinosinusitis with Nasal Polyps, or CRSwNP. This is a long-term problem where soft, non-cancerous growths (nasal polyps) develop inside your nose and sinuses. This can cause various symptoms like a blocked nose, difficulty breathing, reduced sense of smell, and facial pain. Sometimes, these polyps need surgery, but they can often come back.

We are looking at a treatment called mepolizumab, which is a medicine given by injection. It's already approved for treating CRSwNP in some people. In previous studies, mepolizumab greatly improved symptoms and reduced the need for surgery. What's particularly interesting is that some patients have continued to feel much better for a very long time, even years, after they stopped taking the medicine. We don't fully understand why this happens or how to tell who will experience these long-lasting effects. Our study aims to uncover these answers, looking at how the medicine affects the body at a very detailed level.

By understanding why mepolizumab has such a lasting effect in some people, we hope to find ways to predict which patients are most likely to benefit the most. This could eventually help doctors make better decisions about who should receive this treatment and how long they might need it, potentially leading to more effective and personalised care for people living with CRSwNP. We will be studying patients closely to see how their bodies respond to the treatment and what might be different in people who experience longer-lasting improvements.